Evaxion Graham Number from 2010 to 2024

EVAX Stock  USD 1.57  0.04  2.48%   
Evaxion Biotech Graham Number yearly trend continues to be fairly stable with very little volatility. Graham Number is likely to outpace its year average in 2024. During the period from 2010 to 2024, Evaxion Biotech Graham Number regression line of annual values had r-squared of  0.41 and arithmetic mean of  21.98. View All Fundamentals
 
Graham Number  
First Reported
2010-12-31
Previous Quarter
17.74947246
Current Value
33.51
Quarterly Volatility
27.23146134
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Evaxion Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evaxion Biotech's main balance sheet or income statement drivers, such as Interest Income of 1.4 M, Depreciation And Amortization of 330.1 K or Interest Expense of 1 M, as well as many indicators such as Price To Sales Ratio of 206, Dividend Yield of 0.0 or Days Sales Outstanding of 4.3 K. Evaxion financial statements analysis is a perfect complement when working with Evaxion Biotech Valuation or Volatility modules.
  
Check out the analysis of Evaxion Biotech Correlation against competitors.

Latest Evaxion Biotech's Graham Number Growth Pattern

Below is the plot of the Graham Number of Evaxion Biotech AS over the last few years. It is Evaxion Biotech's Graham Number historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evaxion Biotech's overall financial position and show how it may be relating to other accounts over time.
Graham Number10 Years Trend
Slightly volatile
   Graham Number   
       Timeline  

Evaxion Graham Number Regression Statistics

Arithmetic Mean21.98
Geometric Mean12.24
Coefficient Of Variation123.88
Mean Deviation20.21
Median5.61
Standard Deviation27.23
Sample Variance741.55
Range79.9826
R-Value0.64
Mean Square Error469.84
R-Squared0.41
Significance0.01
Slope3.91
Total Sum of Squares10,382

Evaxion Graham Number History

2024 33.51
2023 17.75
2022 82.33
2021 85.59
2020 30.11
2019 29.98

About Evaxion Biotech Financial Statements

Evaxion Biotech investors use historical fundamental indicators, such as Evaxion Biotech's Graham Number, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Evaxion Biotech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Graham Number 17.75  33.51 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Evaxion Stock Analysis

When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.